The mRNA COVID-19 vaccine has allowed us to witness the effectiveness, safety, and tremendous potential of mRNA technology. Currently, research institutions worldwide are targeting cancer as the next goal for mRNA technology.Read More…
Cancer vaccines are one of the most important methods of cancer immunotherapy. The three main factors that determine the efficacy of cancer vaccines are antigen, adjuvant, and formulation. Antigens induce specific immuneRead More…
Therapeutic tumor cells (ThTCs) are expected to become a new class of anticancer drugs because they naturally carry new tumor antigens. This strategy has been proven to induce an anti-tumor immune responseRead More…
Therapeutic tumor cells (ThTC) are expected to become a new class of anticancer drugs because they naturally carry new tumor antigens. This method has been shown to trigger the transfer of powerfulRead More…
Traditional vaccines are committed to the prevention of a variety of infectious diseases, while cancer vaccines, which have attracted much attention in recent years, aim to focus the strength of the humanRead More…
Adenovirus (Ad) vector vaccines have been frequently reported in recent years as the main force against COVID-19. In fact, Ad vaccines have a wide range of applications, and also play an importantRead More…
Tumor vaccine is a promising therapeutic strategy, which produces long-term anti-tumor immunity by stimulating immune responses accordingly. However, due to inefficient vaccination, the clinical efficacy of such vaccines is limited. Recently, inRead More…
In the clinical trial of oncolytic vesicular stomatitis virus expressing interferon-β (VSV-IFN-β), a large group of patients initially achieved a preliminary response, but then the disease relapsed. A few days ago, inRead More…
At present, new antigen vaccines have become a hot direction in the field of cancer immunotherapy. With the release of some positive clinical data and more and more projects entering the clinicalRead More…
Recently, the clinical data on the treatment of two different types of WT1-positive (WT1+) advanced solid tumors with a new cancer vaccine galinpepimut-S (GPS) combined with immune checkpoint inhibitors were released. GPSRead More…